How does a hair transplant work and what can you expect from it?

How does a hair transplant work and what can you expect from it?

It’s never fun to wake up with your pillowcase covered in fallen hair or to spend half an hour unclogging the shower drain every time you wash your hair. But that is the reality of the situation of more than half of the world’s population. Thinning hair and hair loss are much more common than … Read more

Dental Membrane and Bone Graft Substitutes Market to Expand at ~9% CAGR and ~$1.565M in Size

Dental Membrane and Bone Graft Substitutes Market to Expand at ~9% CAGR and ~.565M in Size

The dental membrane and bone graft substitute market is estimated to achieve revenue of USD 1.565 billion by the end of 2033 growing at a CAGR of ~9% by 2033. NEW YORK, UNITED STATES, December 22, 2022 /EINPresswire.com/ — Global Dental Membrane and Bone Graft Substitutes Key Market Insights During the forecast period of 2023~2033, … Read more

Knee Replacement Market Size (2022-2030) Share, Industry Trends, Growth, Challenges, and Forecast – Growth Plus Reports

Knee Replacement Market Size (2022-2030) Share, Industry Trends, Growth, Challenges, and Forecast – Growth Plus Reports

/EIN News/ — Pune, Dec. 16, 2022 (GLOBE NEWSWIRE) — According to the report published by Growth Plus Reports the Global knee replacement market was estimated at $10.34 billion in 2021 and is expected to exceed a valuation of $15.37 billion by 2030, progressing at a rate CAGR of 4.5% from 2022 to 2030. The … Read more

NASDAQ Biopharmaceutical And Wellness Company Troubled Increasing Revenue Substantial Shareholder And Corporate Update; $JUPW

NASDAQ Biopharmaceutical And Wellness Company Troubled Increasing Revenue Substantial Shareholder And Corporate Update;  $JUPW

A handshake of epic proportions could resume at any moment. Virtually impossible to cover short positions. Active Research Programs Developing Multiple Lines of Health and Wellness Products. Growing revenue from consumer products, contract research, and licensing. Appointed new member of the BOD that reported the insider purchase of 122,000 shares. Exclusive license agreement with Rejoy, … Read more

DKSH: Lupine and DKSH sign an exclusive license and supply agreement to commercialize five biosimilars in the Philippines

DKSH: Lupine and DKSH sign an exclusive license and supply agreement to commercialize five biosimilars in the Philippines

Press release Lupine and DKSH sign an exclusive license and supply agreement to commercialize five biosimilars in the Philippines DKSH and Lupine have signed an exclusive license and supply agreement to commercialize five of Alvotech’s high-quality biosimilars in the Philippines. Philippines, August 25, 2022 – DKSH Business Unit Healthcare, a leading partner … Read more

Adaptive Biotechnologies announces the launch of clonoSEQ® to assess minimal residual disease (MRD) in patients with diffuse large B-cell lymphoma (DLBCL) using circulating tumor DNA (ctDNA)

Adaptive Biotechnologies announces the launch of clonoSEQ® to assess minimal residual disease (MRD) in patients with diffuse large B-cell lymphoma (DLBCL) using circulating tumor DNA (ctDNA)

clonoSEQ is the first and only Medicare-covered DLBCL MRD test across all lines of therapy, treatment regimens, and time points Adaptive now accepts blood samples from DLBCL patients in ctDNA-stabilizing Streck® tubes SEATTLE, December 01, 2022 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial-stage biotechnology company that aims to translate the genetics of … Read more

Aquestive Therapeutics Announces Publication of Crossover Study of Dietary Effect of Diazepam Nasal Spray in Epilepsy

Aquestive Therapeutics Announces Publication of Crossover Study of Dietary Effect of Diazepam Nasal Spray in Epilepsy

Peer-reviewed data indicate that food significantly decreases and delays the absorption of diazepam dosed via nasal spray WARREN, NJ, Nov. 29, 2022 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company that advances current standards of care to solve patient problems by simplifying delivery methods complexes, announced today the publication of a pharmacokinetic … Read more

JBM Healthcare Announces Interim Results for Fiscal Year 2023

JBM Healthcare Announces Interim Results for Fiscal Year 2023

HONG KONG, November 25, 2022 – (ACN Newswire) – – JBM (medical care) limited (“JBM Health” or the “Group”; Stock Code: 2161), a leading marketer and distributor of brand name healthcare products in Hong Kongtoday announced the Group’s intermediate results for the semester ended September 30, 2022 (the “Reporting Period”). KEY POINTS — Period-over-period revenue … Read more

Kintor Pharmaceutical: Pharma announced the completion of the Phase I trial of the world’s first PROTAC compound (GT20029) for topical use

Kintor Pharmaceutical: Pharma announced the completion of the Phase I trial of the world’s first PROTAC compound (GT20029) for topical use

Suzhou, November 24, 2022: Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biologic therapies, today announced the key results of its Phase I clinical trial. of GT20029 for the treatment of androgenetic alopecia (AGA) and acne in China, which demonstrated the good safety, tolerability and pharmacokinetics of … Read more

BioSenic – Transparency notifications received from Francois Rieger, Veronique Pomi, Capital Grand Est FA DIESE 3 and CPH Banque

BioSenic – Transparency notifications received from Francois Rieger, Veronique Pomi, Capital Grand Est FA DIESE 3 and CPH Banque

BIOSENIC (Euronext Brussels and Paris: BIOS), the innovative company addressing unmet medical needs in the areas of innate immunity, inflammation and function/organ repair, announces today that it has received transparency notifications from François Rieger, veronique pomiGreat East of the capital, FA DIES 3 and CPH Bank. Details of the notices are below and can be … Read more